1. Inicio
  2. Publicaciones
  3. Quantum-First Trial: FMS-like Tyrosine Kinase 3-Internal Tandem Duplication ( FLT3-ITD)-Specific Measurable Residual Disease (MRD) Clearance Assessed through Induction ( IND) and Consolidation CONS) Is Associated with Improved Overall Survival (OS) in Newly Diagnosed (nd) FLT3-ITD+ AML Patients (pts)

Quantum-First Trial: FMS-like Tyrosine Kinase 3-Internal Tandem Duplication ( FLT3-ITD)-Specific Measurable Residual Disease (MRD) Clearance Assessed through Induction ( IND) and Consolidation CONS) Is Associated with Improved Overall Survival (OS) in Newly Diagnosed (nd) FLT3-ITD+ AML Patients (pts)

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Perl, Alexander
  • Erba, Harry P.
  • Vrhovac, Radovan
  • Patkowska, Elzbieta
  • Kim, Heeje
  • Zak, Pavel
  • Wang, Po-Nan
  • Rohrbach, Jaime E.
  • Chang, Ken C. N.
  • Liu, Li
  • Kamel, Yasser Mostafa
  • Imadalou, Karima
  • Lesegretain, Arnaud
  • Cortes, Jorge
  • Sekeres, Mikkael A.
  • Dombret, Herve
  • Amadori, Sergio
  • Wang, Jianxiang
  • Schlenk, Richard F.
  • Levis, Mark J.

Grupos

Abstract

Abstract no disponible

Datos de la publicación

ISSN/ISSNe:
0006-4971, 1528-0020

BLOOD  ELSEVIER

Tipo:
Meeting Abstract
Páginas:
-
Factor de Impacto:
4,834 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 5

Documentos

  • No hay documentos

Métricas

Filiaciones

Filiaciones no disponibles

Campos de Estudio

Compartir